Prenylated flavonoids from Dalea genus as xanthine oxidase inhibitors: in vitro bioactivity evaluation and molecular docking studies

Dublin Core

Título

Prenylated flavonoids from Dalea genus as xanthine oxidase inhibitors: in vitro bioactivity evaluation and molecular docking studies

Tema

FLAVONOIDES
XANTINA OXIDASA
ACOPLAMIENTO MOLECULAR
HIPERURICEMIA
BIBLIOGRAFIA NACIONAL QUIMICA
2023

Abstract

Prenylated flavanones are a family of compounds with an important biological potential. Previously, anti tyrosinase activity, acetylcholinesterase inhibitory activity, and neuroprotective effects of several prenyl flava nones isolated from different American Dalea genus species were reported. The biological potency of these kinds of compounds, together with the particularity of their chemical structures, encouraged us to investigate them for in vitro and in silico anti-xanthine oxidase activity. So, five prenyl-flavanones obtained from different Dalea sp (Dalea elegans, Dalea boliviana, and Dalea pazensis) were studied and the relationships between the structure of these prenyl-flavanones and their inhibitory activity were evaluated. Molecular docking studies were performed in order to propose the binding mode of the most active natural compound. 2′,4′-dihydroxy-5′-(1‴,1‴-dimethy lallyl)-8-prenylpinocembrin (1) was the most active in this series showing an IC50 of 0.26 ± 0.07 µM comparable with the reference inhibitor, allopurinol. The presence of 5,7,2′,4′-tetrahydroxy substitution, accompanied by a prenyl group at 8-position in the A-ring, and a 5′ (1‴,1‴-dimethylallyl) were important to present a xanthine oxidase inhibitory activity. This fact was confirmed with molecular docking studies showing relevant interactions of 1 with the residues of the catalytic site of xanthine oxidase, and a binding energy of − 7.3297 kcal mol− 1 . These results contributed not only to understanding the binding mode but also to validating the in vitro results. The obtained findings lead us to propose these prenyl-flavanones as lead compounds for the design and devel opment of novel xanthine oxidase inhibitors for the treatment of diseases in which this enzyme is involved.

Autor

Santi, M.D.
Bedoya Aguirre, E.
Negro, M.F.
Zunini, M. Paulino
Peralta, M.A.
Ortega, M. G.

Fuente

Results in Chemistry v.6, 2023. -- e101115

Editor

Elsevier

Fecha

2023

Derechos

Información sobre Derechos de Autor

(Por favor lea este aviso antes de abrir los documentos u objetos)

La legislación uruguaya protege el derecho de autor sobre toda creación literaria, científica o artística, tanto en lo que tiene que ver con sus derechos morales, como en lo referente a los derechos patrimoniales con sujeción a lo establecido por el derecho común y las siguientes leyes (LEY 9.739 DE 17 DE DICIEMBRE DE 1937 SOBRE PROPIEDAD LITERARIA Y ARTISTICA CON LAS MODIFICACIONES INTRODUCIDAS POR LA LEY DE DERECHO DE AUTOR Y DERECHOS CONEXOS No. 17.616 DE 10 DE ENERO DE 2003, LEY 17.805 DE 26 DE AGOSTO DE 2004, LEY 18.046 DE 24 DE OCTUBRE DE 2006 LEY 18.046 DE 24 DE OCTUBRE DE 2006)

ADVERTENCIA - La consulta de este documento queda condicionada a la aceptación de las siguientes condiciones de uso: Este documento es únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con fines de lucro. Esta reserva de derechos afecta tanto los datos del documento como a sus contenidos. En la utilización o cita de partes debe indicarse el nombre de la persona autora.

Formato

PDF

Extent

7 p.

Idioma

Inglés

Tipo

Artículo

Identificador

10.1016/j.rechem.2023.101115

Document Item Type Metadata

Original Format

PDF
Fecha de agregación
October 30, 2023
Colección
Bibliografía Nacional Química
Tipo de Elemento
Document
Etiquetas
, , ,
Citación
Santi, M.D., “Prenylated flavonoids from Dalea genus as xanthine oxidase inhibitors: in vitro bioactivity evaluation and molecular docking studies,” RIQUIM - Repositorio Institucional de la Facultad de Química - UdelaR, accessed May 2, 2024, https://riquim.fq.edu.uy/items/show/6732.
Archivos